Metabolic responses to selective beta-adrenergic stimulation in man
- PMID: 1114148
- PMCID: PMC2495720
- DOI: 10.1136/pgmj.51.592.53
Metabolic responses to selective beta-adrenergic stimulation in man
Abstract
The responses of plasma free fatty acid, glucose, lactate, insulin and growth hormone to intravenous administration of the predominantly β-2 stimulant, salbutamol, were studied in nine normal subjects. Four subjects received the predominantly β-1 blocking agent, practolol, together with salbutamol.
Salbutamol produced a marked rise in free fatty acid levels and there was also an appreciable increase in insulin values; lactate levels rose moderately and glucose values increased slightly; growth hormone levels were not affected. Practolol did not alter the free fatty acid response; it diminished but did not appear to abolish the insulin response, and it appeared to suppress the lactate and glucose rises.
Tentative proposals are made regarding the nature of the β-receptor subtypes responsible for mediating these effects; most definite is the suggestion that lipolysis is subserved by β-2 receptors. Possible clinical implications are briefly discussed.
Similar articles
-
Practolol inhibition of some salbutamol-induced metabolic and hormonal responses.Acta Diabetol Lat. 1977 Sep-Dec;14(5-6):257-62. doi: 10.1007/BF02580974. Acta Diabetol Lat. 1977. PMID: 207065
-
[Effect of adrenergic beta-blockade using trimepranol on glucose, insulin, somatotropin and nonesterified fatty acids in the blood of women with diabetes mellitus].Vnitr Lek. 1974 Nov;20(11):1050-4. Vnitr Lek. 1974. PMID: 4155166 Czech. No abstract available.
-
Metabolic effects of oral salbutamol.Br Med J. 1976 Jan 3;1(6000):22. doi: 10.1136/bmj.1.6000.22. Br Med J. 1976. PMID: 764913 Free PMC article. Clinical Trial. No abstract available.
-
Effect of trimepranol, a beta blocker, on plasma levels of growth hormone, insulin, glucose, and free fatty acids.Clin Pharmacol Ther. 1973 Sep-Oct;14(5):881-5. doi: 10.1002/cpt1973145881. Clin Pharmacol Ther. 1973. PMID: 4147123 Clinical Trial. No abstract available.
-
The hormonal response to physical exercise.Australas Ann Med. 1969 May;18(2):84-90. doi: 10.1111/imj.1969.18.2.84. Australas Ann Med. 1969. PMID: 4894730 Review. No abstract available.
Cited by
-
The metabolic actions of intravenous salbutamol and aminophylline singly and in combination.Br J Clin Pharmacol. 1981 Feb;11(2):197-201. doi: 10.1111/j.1365-2125.1981.tb01124.x. Br J Clin Pharmacol. 1981. PMID: 7011349 Free PMC article. Clinical Trial.
-
Assessment of work performance in asthma for determination of cardiorespiratory fitness and training capacity.Thorax. 1988 Oct;43(10):745-9. doi: 10.1136/thx.43.10.745. Thorax. 1988. PMID: 3206382 Free PMC article.
-
Metabolic effects of intravenous salbutamol in the course of acute severe asthma.Thorax. 1977 Oct;32(5):559-62. doi: 10.1136/thx.32.5.559. Thorax. 1977. PMID: 594936 Free PMC article.
-
Beta-adrenoceptor blocking agents and lipolysis.Br J Clin Pharmacol. 1982;13(Suppl 2):181S-186S. doi: 10.1111/j.1365-2125.1982.tb01908.x. Br J Clin Pharmacol. 1982. PMID: 6125168 Free PMC article. Review.
-
Metabolic response to intravenous salbutamol therapy in acute asthma.Thorax. 1977 Apr;32(2):182-4. doi: 10.1136/thx.32.2.182. Thorax. 1977. PMID: 867331 Free PMC article.